Investors in Health

At Lauxera Capital Partners, we are an independent, international asset management company focused on healthcare. Our expertise lies in growth equity investments, particularly in commercial-stage medical devices, digital health, life sciences tools, and healthcare data companies. Led by entrepreneurial company builders and seasoned healthcare investors with extensive experience across international markets, we empower European healthtech entrepreneurs to realize the growth potential of their innovations.

Dreamcraft invests in European tech-driven companies from pre-seed to series A. We believe success is created by a team mixed with dreamers and crafters - and we are venture engineers who help the two. The right founders love our engagements that go deeper than just advice.Hands-on venture engineers for talented founders.

Nordic Alpha Partners is a growth fund that invests in hard-tech companies with potential to drive global market transformations.Nordic Alpha Partners is specialized in managing the complexity of scaling industrial GreenTech, enabling visionary founders to successfully grow from local players to global market leaders.

Catapult Ventures is led by some of the most experienced venture capital investors in the UK. Our team's expertise spans diverse sectors including healthcare, pharmaceuticals, luxury consumer brands, manufacturing, and software. We engage across all stages of company growth, from supporting startups and pre-revenue IP developers to managing company floatations and overseeing billions of pounds in revenue. At Catapult Ventures, we prioritize value creation through long-term relationships with both our portfolio companies and the investors in our managed funds. Each member of our executive team holds direct portfolio responsibility, actively serving as board members who shape investee company strategies, contribute to senior personnel hires, and sometimes even facilitate customer engagements. Our executives are integral to financial strategy, leveraging banking relationships and introducing new investors for additional funding rounds as needed. As an independent fund manager, Catapult Ventures has successfully operated numerous discrete venture capital funds on behalf of a range of public and private sector investors, totaling approximately £130 million.

The Innovatiefonds Noord-Holland supports SMEs and startups in the Province of North Holland with financing for early-stage innovation. We provide convertible loans for Proof-of-Concept projects up to 350,000 euros, enabling entrepreneurs to bring their innovative ideas to fruition. The fund was established by the Province of North Holland, UvA Ventures Holding BV, Vrije Universiteit, AMC Ventures Holding BV, HvA Ventures Holding BV, and Sanquin Innovatie BV, and is supported by Europe via the European Regional Development Fund and the RVO. Our aim is to foster a thriving ecosystem for innovation by providing essential financial resources and strategic support

Esperante, a corporate venture capital firm affiliated with a global life science group, boasts leadership with deep operational expertise in the development, manufacturing, and global marketing of prescription pharmaceuticals and in vitro clinical diagnostic tests. Since its establishment in 2004, Esperante has strategically invested in 24 pharmaceutical and diagnostic companies across the US, UK, continental Europe, and Israel. Notably, the firm has achieved three successful exits: Thiakis to Wyeth/Pfizer, Pinnacle Biologics to Concordia, and Haemostatix to Ergomed. Currently, four portfolio companies are publicly listed in the US, Canada, and UK, with a focus on therapeutics in advanced clinical stages and diagnostics companies entering the European market. Esperante pursues initial investments of up to EUR 2,000,000 per venture in collaboration with other investors, aiming for exits through sales or liquidity events within a three-year timeframe.

Within the business climate around knowledge centres UG/UMCG there is an increase of start-ups and initiatives to investigate the possibilities there to. The most promising companies will at a certain moment search for venture capital to finance their growth. Carduso Capital wants to participate in this type of companies by putting in, besides capital, also their strategic knowledge. Carduso Capital recognises the several development stages of this type of companies.

Abingworth is a distinguished international investment firm specializing in the life sciences and healthcare sectors. Founded in 1973, we have a long-standing reputation for supporting innovative companies at various stages of development, from early-stage startups to late-stage growth enterprises. Our investment portfolio spans biotechnology, pharmaceuticals, medical devices, and healthcare services, reflecting our commitment to advancing cutting-edge technologies and treatments. With our team of seasoned professionals bringing deep industry knowledge and extensive experience, we provide strategic guidance and operational support to our portfolio companies. Our global presence, with offices in London, Menlo Park, and Boston, allows us to identify and invest in promising opportunities worldwide. Dedicated to fostering innovation and improving patient outcomes, we have successfully supported numerous companies in achieving significant milestones, demonstrating our ability to add value and drive growth.

XO Ventures is a venture capital investment firm based in the heart of Silicon Valley, specializing in early-stage technology startups. With a focus on disruptive innovations, XO Ventures provides strategic capital and mentorship to entrepreneurs across various sectors including AI, biotech, and fintech. Their team of experienced investors and advisors supports startups through the critical phases of growth, aiming to accelerate their development and market entry. XO Ventures is committed to fostering innovation and driving forward groundbreaking technologies that have the

Sky Man Ventures is an innovative investment firm specializing in early-stage and growth-stage opportunities across diverse sectors. Based on their proactive investment strategy, they seek out promising startups with disruptive potential and provide strategic capital and operational support to foster their growth. Sky Man Ventures prioritizes sustainable and scalable business models, aiming to create long-term value for both entrepreneurs and investors alike.

Maven 11 Capital is a venture capital fund focused on the blockchain and crypto space. Based in Amsterdam and the Cayman Islands, Maven 11 partners with innovative founders who are redefining ownership through open and inclusive crypto networks. They emphasize active participation, technical fluency, and long-term relationships with their portfolio companies. Maven 11 supports entrepreneurs from inception to growth, with a focus on bold and early-stage investments in the blockchain and crypto sectors.

We are a Venture Capital fund supporting students and recent graduate founded startups with funding, a community of young entrepreneurs, and our network of industry experts and investors. At ASIF, we bridge the gap between student entrepreneurs and venture capital funding. Our goal is to spur entrepreneurship in the Amsterdam Metropolitan Area by guiding and investing in student-led startups. We are here to support student & recent graduate startups from the get-go.